Title: A2444 1R
Official Title: 
Number of Sections: 1
Source: versions - Reprint AHE 2/22/24 1R
Media Type: text/html

================================================================================

Section 1:
A2444 1R [First Reprint] ASSEMBLY, No. 2444 STATE OF NEW JERSEY 221st LEGISLATURE PRE-FILED FOR INTRODUCTION IN THE 2024 SESSION Sponsored by: Assemblywoman  ANNETTE QUIJANO District 20 (Union) Assemblywoman  SHAMA A. HAIDER District 37 (Bergen) Assemblywoman  TENNILLE R. MCCOY District 14 (Mercer and Middlesex) Co-Sponsored by: Assemblyman Atkins, Assemblywoman Speight, Assemblyman Conaway, Assemblywomen Katz, Hall, Bagolie and Carter SYNOPSIS Requires DOH to study racial aspects of ovarian cancer. CURRENT VERSION OF TEXT As reported by the Assembly Health Committee on Februaary 22, 2024, with amendments. An Act concerning racial aspects of ovarian cancer. Be It Enacted by the Senate and General Assembly of the State of New Jersey: 1. a.  The Commissioner of Health shall conduct a study of the racial aspects of ovarian cancer.  The purpose of the study shall be to 1[determine whether there are differences] evaluate strategies that would mitigate disparities1 in ovarian cancer effects, rates, risk factors, symptoms, and outcomes among women who are members of racial and ethnic groups that shall include but shall not be limited to:  Asian, African-American, Caucasian, Hispanic, Native American, and Pacific Islander. b.   Within one year after the date of enactment of this act, the Commissioner of Health shall prepare and submit to the Governor and, pursuant to section 2 of P.L.1991, c.164 (C.52:14-19.1), to the Legislature, a report containing the study's findings 1and recommendations to address the impact of racial disparities on ovarian cancer rates among racial and ethnic minorities1 . 2.    This act shall take effect immediately and shall expire upon the submission of the report pursuant to subsection b. of section 1.


================================================================================

Raw Text:
A2444 1R [First Reprint] ASSEMBLY, No. 2444 STATE OF NEW JERSEY 221st LEGISLATURE PRE-FILED FOR INTRODUCTION IN THE 2024 SESSION Sponsored by: Assemblywoman  ANNETTE QUIJANO District 20 (Union) Assemblywoman  SHAMA A. HAIDER District 37 (Bergen) Assemblywoman  TENNILLE R. MCCOY District 14 (Mercer and Middlesex) Co-Sponsored by: Assemblyman Atkins, Assemblywoman Speight, Assemblyman Conaway, Assemblywomen Katz, Hall, Bagolie and Carter SYNOPSIS Requires DOH to study racial aspects of ovarian cancer. CURRENT VERSION OF TEXT As reported by the Assembly Health Committee on Februaary 22, 2024, with amendments. An Act concerning racial aspects of ovarian cancer. Be It Enacted by the Senate and General Assembly of the State of New Jersey: 1. a.  The Commissioner of Health shall conduct a study of the racial aspects of ovarian cancer.  The purpose of the study shall be to 1[determine whether there are differences] evaluate strategies that would mitigate disparities1 in ovarian cancer effects, rates, risk factors, symptoms, and outcomes among women who are members of racial and ethnic groups that shall include but shall not be limited to:  Asian, African-American, Caucasian, Hispanic, Native American, and Pacific Islander. b.   Within one year after the date of enactment of this act, the Commissioner of Health shall prepare and submit to the Governor and, pursuant to section 2 of P.L.1991, c.164 (C.52:14-19.1), to the Legislature, a report containing the study's findings 1and recommendations to address the impact of racial disparities on ovarian cancer rates among racial and ethnic minorities1 . 2.    This act shall take effect immediately and shall expire upon the submission of the report pursuant to subsection b. of section 1.